Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Blocker Therapy: Current Update.

Steven A Kaplan

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Alpha-blockers are key for benign prostatic hyperplasia (BPH) symptom relief. Tamsulosin, a new alpha(1A)-specific agent, targets prostate smooth muscle, reducing side effects for effective BPH treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Re: 80-W GreenLight Laser Vaporization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Obstruction: 5-Year Outcomes of a Single-Center Prospective Randomized Trial.

    The Journal of urology·2019
    Same author

    Re: Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.

    The Journal of urology·2019
    Same author

    Re: Learning Curves and Perioperative Outcomes after Endoscopic Enucleation of the Prostate: A Comparison between GreenLight 532-nm and Holmium Lasers.

    The Journal of urology·2019
    Same author

    Re: Association between Chronic Obstructive Pulmonary Disease and Increased Risk of Benign Prostatic Hyperplasia: A Retrospective Nationwide Cohort Study.

    The Journal of urology·2019
    Same author

    Re: Efficacy and Safety of Prostate Artery Embolization for Benign Prostatic Hyperplasia: .

    The Journal of urology·2019
    Same author

    Re: Comparison of Perioperative Outcomes between Holmium Laser Enucleation of the Prostate and Robot-Assisted Simple Prostatectomy.

    The Journal of urology·2019

    Area of Science:

    • Pharmacology
    • Urology

    Background:

    • Alpha-blockade is the primary medical therapy for symptomatic bladder outlet obstruction in benign prostatic hyperplasia (BPH).
    • Human alpha(1) receptors exist in subtypes, with alpha(1A) mediating prostatic smooth muscle contraction.

    Purpose of the Study:

    • To evaluate the efficacy and safety of tamsulosin, an alpha(1A)-specific antagonist, for BPH treatment.
    • To assess the potential for targeted alpha-blockade in prostatic smooth muscle.

    Main Methods:

    • Review of clinical data and FDA approval of tamsulosin.
    • Pharmacologic analysis of alpha(1A)-specific antagonism.

    Main Results:

    • Tamsulosin selectively targets alpha(1A) receptors in prostatic smooth muscle.

    Related Experiment Videos

  • This selectivity spares vascular smooth muscle, leading to fewer cardiovascular side effects.
  • Lower incidence of clinically relevant effects on blood pressure and heart rate observed.

    • Conclusions:

    • Tamsulosin offers a targeted approach to BPH treatment by selectively blocking alpha(1A) receptors.
    • The drug provides effective symptom relief with a favorable cardiovascular safety profile.
    • Selective alpha(1)-blockers represent an advancement in managing benign prostatic hyperplasia.